Endocyte, Inc. Announces First Quarter 2013 Earnings Conference Call

WEST LAFAYETTE, Ind., April 18, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that the company will host a conference call on Thursday, May 2, at 4:30 p.m. EDT to discuss its first quarter 2013 financial results and provide an operational update.